Comments
Loading...
Orchestra BioMed Hldgs Earnings Estimates, EPS & Revenue | NASDAQ:OBIO | Benzinga
Orchestra BioMed Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 11
EPS Estimate
$-0.504
Quarterly Revenue Estimate
$695.60K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.89M
Analyze the earnings history of Orchestra BioMed Hldgs using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
OBIO | Orchestra BioMed Hldgs | -$0.45 | -$0.50 | — | — | $778.00K | $695.60K | — | — | 08/11/2025 | |
OBIO | Orchestra BioMed Hldgs | -$0.38 | -$0.50 | -$0.49 | -2.08% | $620.00K | $809.00K | $868.00K | 57.59% | 05/12/2025 | |
OBIO | Orchestra BioMed Hldgs | -$0.37 | -$0.46 | -$0.43 | 0.00% | $262.00K | $905.20K | $253.00K | -69.50% | 03/31/2025 | |
OBIO | Orchestra BioMed Hldgs | -$0.38 | -$0.42 | -$0.41 | 4.65% | $419.00K | $804.25K | $987.00K | 39.01% | 11/12/2024 | |
OBIO | Orchestra BioMed Hldgs | -$0.35 | -$0.40 | -$0.45 | -15.38% | $915.00K | $772.75K | $778.00K | 3.73% | 08/12/2024 | |
OBIO | Orchestra BioMed Hldgs | -$0.40 | -$0.41 | -$0.38 | 7.32% | $1.16M | $940.00K | $620.00K | -34.04% | 05/13/2024 | |
OBIO | Orchestra BioMed Hldgs | -$0.07 | -$0.38 | -$0.37 | 2.63% | $0.00 | $990.00K | $262.00K | -73.54% | 03/27/2024 | |
OBIO | Orchestra BioMed Hldgs | -$0.51 | -$0.39 | -$0.38 | 2.56% | $1.16M | $890.00K | $419.00K | -52.92% | 11/13/2023 | |
OBIO | Orchestra BioMed Hldgs | -$0.77 | -$0.41 | -$0.35 | 14.63% | $401.00K | $710.00K | $915.00K | 28.87% | 08/10/2023 | |
OBIO | Orchestra BioMed Hldgs | — | -$0.28 | -$0.40 | -42.86% | — | $680.00K | $1.16M | 71.18% | 05/12/2023 | |
OBIO | Orchestra BioMed Hldgs | — | -$1.71 | -$0.07 | 95.91% | — | $1.18M | $0.00 | -100.00% | 01/25/2023 |
Orchestra BioMed Hldgs (OBIO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $-0.49 | $-0.50 | -2.08 % |
| Q4 | 2025-03-31 | $-0.43 | $-0.46 | 0.00 % |
| Q3 | 2024-11-12 | $-0.41 | $-0.42 | 4.65 % |
| Q2 | 2024-08-12 | $-0.45 | $-0.40 | -15.4 % |
Orchestra BioMed Hldgs (OBIO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $868.00K | $809.00K | 57.6 % |
| Q4 | 2025-03-31 | $253.00K | $905.20K | -69.5 % |
| Q3 | 2024-11-12 | $987.00K | $804.25K | 39.0 % |
| Q2 | 2024-08-12 | $778.00K | $772.75K | 3.73 % |
FAQ
When is Orchestra BioMed Hldgs (NASDAQ:OBIO) reporting earnings?
Orchestra BioMed Hldgs (OBIO) is scheduled to report earnings on August 11, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for Orchestra BioMed Hldgs (NASDAQ:OBIO)?
The Actual EPS was $-0.49, which beat the estimate of $-0.50.
What were Orchestra BioMed Hldgs’s (NASDAQ:OBIO) revenues?
The Actual Revenue was $868K, which beat the estimate of $809K.
Browse earnings estimates, EPS, and revenue on all stocks.
